Covered recipient · General Payments record
RUTH MENESES-TAYLOR
General Payments · PY2019–2025
$7,709.84
- Reported across 171 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,197.04 | 15 |
| Education | $15.38 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $573.18 | 6 |
| Amgen Inc. | $306.56 | 5 |
| CALLIDITAS THERAPEUTICS US INC. | $145.06 | 1 |
| Lilly USA, LLC | $107.95 | 1 |
| Curonix LLC | $41.85 | 1 |
| Ardelyx, Inc. | $22.44 | 1 |
| OPKO Pharmaceuticals, LLC | $15.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $130.00 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228352454 | CMS |
| Amgen Inc. | $130.00 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228352456 | CMS |
| Amgen Inc. | $20.49 | 03/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228352458 | CMS |
| Amgen Inc. | $14.11 | 07/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227050734 | CMS |
| Amgen Inc. | $11.96 | 08/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227050736 | CMS |
| Ardelyx, Inc. | $22.44 | 11/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247867421 | CMS |
| AstraZeneca Pharmaceuticals LP | $79.08 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1215346576 | CMS |
| AstraZeneca Pharmaceuticals LP | $108.66 | 02/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214792431 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.64 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214796470 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214803210 | CMS |
| AstraZeneca Pharmaceuticals LP | $118.28 | 08/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1215350491 | CMS |
| AstraZeneca Pharmaceuticals LP | $126.52 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1215341516 | CMS |
| Calliditas Therapeutics US Inc. | $145.06 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235002290 | CMS |
| Curonix LLC | $41.85 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240382031 | CMS |
| Lilly USA, LLC | $107.95 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186902062 | CMS |
| OPKO Pharmaceuticals, LLC | $15.38 | 12/03/2025 | Education | Undisputed | 06/30/2026 | 1222086678 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.